MEK1/2 (phospho-S218/222) polyclonal antibody

Q02750/P36507

MEK1 (Mitogen activated protein kinase kinase 1) catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. MEK1 activates ERK1 and ERK2 MAP kinases. Mitogen activated protein kinase kinase 2 (MEK2 or MAPKK2) is a member of a family of tyrosine/threonine protein kinases that activate the ERK1 and 2 and MAPK enzymes by phosphorylating both residues within the threonine/glutamate/tyrosine (TEY) motif in the activation loop. MEK1 and 2 are also activated by dual phosphorylation, which occurs on serine 218 and 222, in the activation loop of the MEK. Threonine 292 of MEK1 is phosphorylated by ERK 2, which serves as a negative feedback loop by suppressing activation of MEK1.

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).

p-MEK1/2 (S218/222) pAb detects endogenous levels of MEK-1 protein only when phosphorylated at Ser218. This antibody also detects endogenous levels of MEK-2 protein only when phosphorylated at Thr222.

Immunohistochemistry (IHC) analyzes of p-MEK1/2 (S218/222) pAb in paraffin-embedded human breast carcinoma tissue.

For research use only, not for use in diagnostic procedure.

Synthetic phosphopeptide derived from human MEK1 around the phosphorylation site of Serine 218.